e-learning
resources
Amsterdam 2011
Sunday, 25.09.2011
Tuberculin skin tests, interferon-gamma release assays and beyond
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Indeterminate IGRA results in routine practice
P. Kewin, T. Inkster, B. Choo-Kang (Glasgow, United Kingdom)
Source:
Annual Congress 2011 - Tuberculin skin tests, interferon-gamma release assays and beyond
Session:
Tuberculin skin tests, interferon-gamma release assays and beyond
Session type:
Poster Discussion
Number:
304
Disease area:
Respiratory infections
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
P. Kewin, T. Inkster, B. Choo-Kang (Glasgow, United Kingdom). Indeterminate IGRA results in routine practice. Eur Respir J 2011; 38: Suppl. 55, 304
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Evaluating 17 years of latent tuberculosis infection screening in north-west England: a retrospective cohort study of reactivation
Tuberculosis in renal transplant recipients on isoniazid prophylaxis
Diagnosis of Latent TB Infection: the role of IGRAs
Related content which might interest you:
Indeterminate results of quantiFERON TB-2G test performed in routine clinical practice
Source: Annual Congress 2008 - Interferon-gamma release assay tests for diagnosing tuberculosis infection and disease
Year: 2008
Indeterminate results of QuantiFERON TB-2G test performed in routine clinical practice
Source: Eur Respir J 2009; 33: 812-815
Year: 2009
Frequency and significance of indeterminate and borderline Quantiferon Gold TB IGRA results
Source: Eur Respir J, 50 (4) 1701267; 10.1183/13993003.01267-2017
Year: 2017
Clinical history and IGRA is unreliable in the diagnosis of tuberculosis
Source: Annual Congress 2011 - Risk assessment for tuberculosis
Year: 2011
IGRA testing correlation with clinical and laboratory parameters in patients with tuberculosis
Source: Annual Congress 2011 - Risk assessment for tuberculosis
Year: 2011
Indeterminate results of the quantiFERON®TB gold (QFT) in hospitalized patients at risk for MTB infection/disease
Source: Annual Congress 2008 - Interferon-gamma release assay tests for diagnosing tuberculosis infection and disease
Year: 2008
Concordance between IGRA and TST in a cohort of health professional trainees from India
Source: Annual Congress 2011 - Risk assessment for tuberculosis
Year: 2011
IGRA testing to diagnose TB disease and infection. What is new in clinical practice and for programmatic management
Source: School Course 2012 - TB and M/XDR-TB: from clinical management to control and elimination
Year: 2012
The changing indications for IGRA testing and impact on TB services in a UK district general hospital
Source: Annual Congress 2013 –Immunological diagnosis of tuberculosis and latent tuberculosis infection
Year: 2013
Prevalence of LTBI using IGRA and TST in a cohort of health professional trainees from India
Source: Annual Congress 2011 - Risk assessment for tuberculosis
Year: 2011
Results of IGRA tests in a prison from a high-TB burden country
Source: Annual Congress 2010 - Immune responses for the diagnosis of tuberculosis
Year: 2010
Do adjunct tuberculosis tests, when combined with Xpert MTB/RIF, improve accuracy and the cost of diagnosis in a resource-poor setting?
Source: Eur Respir J 2012; 40: 161-168
Year: 2012
A retrospective review of the Xpert® MTB/RIF assay performance in bronchoalveolar lavage samples in a London hospital
Source: Annual Congress 2013 –Tuberculosis diagnosis
Year: 2013
Improved diagnostic evaluation of suspected tuberculosis in routine practice
Source: Annual Congress 2008 - New tools in tuberculosis diagnosis
Year: 2008
Discordance between tuberculin skin tests (TST) and interferon gamma release assays (IGRAs): Are we over-treating LTBI?
Source: International Congress 2018 – Tuberculosis transmission and screening strategies
Year: 2018
Evaluation of IP-10 in IGRA for LTBI diagnosis
Source: International Congress 2018 – Tuberculosis transmission and screening strategies
Year: 2018
Molecular diagnosis of tuberculosis in a north Italian clinical setting: results of routine use of a commercial LCR-based test
Source: Eur Respir J 2001; 18: Suppl. 33, 360s
Year: 2001
Clinical utility of the Xpert MTB/RIF test in induced sputum
Source: International Congress 2015 – WHO guidelines in TB and clinical practice
Year: 2015
Low real-world utility of IGRA when screening for LTBI in a low incidence setting
Source: International Congress 2015 – Screening strategies in TB
Year: 2015
Tuberculin skin test and IGRA test in the diagnosis and follow-up of bacteriologically confirmed pulmonary tuberculosis in HIV negative adults
Source: Annual Congress 2012 - Tuberculosis and immunologic assays
Year: 2012
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept